Delivery Order SPE2DB20D3303-SPE2DB24FZ9S8

Award Date 6/11/24
Potential Completion Date 6/12/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, is for the delivery of the pharmaceutical product Mounjaro 7.5 mg/0.5 ml pen (0.5 ml) to the Defense Logistics Agency (DLA). The contract has a ceiling value of $8,939.84 and a completion date of June 11, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of Mounjaro 7.5 mg/0.5 ml pens to the U.S. government. The contract, valued at $30,363.92, was awarded by the Defense Logistics Agency (DLA) and has a completion date of July 2, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle for the company to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product Mounjaro 15 mg/0.5 ml pen with a ceiling value of $2,630.00. The contract, awarded by the Defense Logistics Agency (DLA), is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML. The contract, awarded by the Defense Logistics Agency (DLA), is a Delivery Order with a Firm Fixed Price of $1,052.00 and an ultimate completion date of May 21, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract, with a ceiling value of $3,104.08, was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of June 13, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the procurement of pharmaceutical products, specifically the drug Mounjaro 10 mg/0.5 mL pen, for a ceiling value of $2,448.84. The contract is a delivery order issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 25, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued...
This federal contract award to AmerisourceBergen Drug Corp, Corporate Office Division, is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense, and has a ceiling value of $2,802.89. The contract is a Delivery Order with a Firm Fixed Price pricing type, has no set-aside designation, and has an ultimate completion date of August 28, 2024....
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product Mounjaro 2.5 mg/0.5 ml pen with a 0.5 ml dosage. The contract has a firm fixed price of $1,369.56 and a completion date of June 25, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division has a ceiling value of $3,274.36 and covers the delivery order for 4564429761 - MOUNJARO 10 MG/0.5 ML PEN 0.5ML. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical on April 29, 2024 with an ultimate completion date of April 30, 2024. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of the pharmaceutical product Mounjaro 7.5 mg/0.5 mL pen. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, has a ceiling value of $1,415.44 and a completion date of July 29, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025....
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FZ9S8
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) for the delivery of Mounjaro 12.5 mg/0.5 ml pen 0.5 ml. The award has a ceiling value of $1,315.00 and a completion date of June 12, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This specific award is not designated as a set-aside contract.

Generated 9/10/24, 9:56 AM